NCT05898919

Brief Summary

The goal of this study is to examine the efficacy of acupuncture in the management of acute postoperative urinary retention. Clinical question: Is acupuncture efficacious for postoperative urinary retention after hemorrhoidectomy compared with sham acupuncture and neostigmine. Study design: The participants who undergo hemorrhoidectomy and report postoperative urinary retention will receive one session of acupuncture or sham acupuncture or one injection of 1-mg neostigmine. The primary outcome was the time to first urination after surgery.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
92

participants targeted

Target at P50-P75 for phase_2

Timeline
Completed

Started Mar 2022

Shorter than P25 for phase_2

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2022

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 25, 2023

Completed
2 days until next milestone

First Submitted

Initial submission to the registry

May 27, 2023

Completed
16 days until next milestone

First Posted

Study publicly available on registry

June 12, 2023

Completed
24 days until next milestone

Study Completion

Last participant's last visit for all outcomes

July 6, 2023

Completed
Last Updated

July 10, 2023

Status Verified

July 1, 2023

Enrollment Period

1.2 years

First QC Date

May 27, 2023

Last Update Submit

July 7, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • The time to first urination after surgery

    This outcome records the time period from the end of surgery to the immediately first urination.

    Immediately after first urination

Secondary Outcomes (6)

  • The volume of first of urination

    Immediately after first urination

  • Bladder residual urine volume

    10 minutes before treatment, 0.5, 1, and 2 hours after treatment.

  • Urination Score

    10 minutes before treatment, 0.5, 1, and 2 hours after treatment.

  • Abdominal symptom score

    Before treatment, 0.5, 1, and 2 hours after treatment.

  • Visual analogue score after surgery

    2 hours after treatment.

  • +1 more secondary outcomes

Study Arms (3)

Acupuncture

EXPERIMENTAL
Other: Acupuncture

Sham acupuncture

PLACEBO COMPARATOR
Other: Sham acupuncture

Neostigmine

ACTIVE COMPARATOR
Drug: Neostigmine Injectable Product

Interventions

Acupuncture is a technique that inserts a needle into the acupuncture point to treat a condition. In this trial, we will use acupuncture to treat postoperative urinary retention.

Acupuncture

Participants will receive sham acupuncture at sham points.

Sham acupuncture

Neostigmine was injected once after postoperative urinary retention.

Neostigmine

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Aged between 18 and 65 years
  • Meets the diagnostic criteria of postoperative urinary retention
  • Received milligan-morgan hemorrhoidectomy and general anesthesia

You may not qualify if:

  • Received Diuretic drugs
  • Organic diseases that cause urinary retention
  • Severe infection in the urinary tract
  • Has a history of adverse reaction to neostigmine
  • Cognitive dysfunction that affects outcome assessment
  • Being pregnant

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital of Chengdu University of Traditional Chinese Medicine

Chengdu, 610000, China

Location

MeSH Terms

Conditions

Postoperative Complications

Interventions

Acupuncture Therapy

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Complementary TherapiesTherapeutics

Study Officials

  • Min Chen, MD

    Chengdu University of Traditional Chinese Medicine

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Professor

Study Record Dates

First Submitted

May 27, 2023

First Posted

June 12, 2023

Study Start

March 1, 2022

Primary Completion

May 25, 2023

Study Completion

July 6, 2023

Last Updated

July 10, 2023

Record last verified: 2023-07

Locations